OpenURL Connection Search

Select item for more details and to access through your institution.

Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
Published in:
2012
By:
- Lê MP;
- Solas C;
- Garraffo R;
- Gagnieu MC;
- Muret P;
- Yeni P;
- Dhiver C;
- Katlama C;
- Poizot-Martin I;
- Durant J;
- Peytavin G
Publication type:
Journal Article
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
Published in:
2012
By:
- Marcelin AG;
- Charpentier C;
- Wirden M;
- Landman R;
- Valantin MA;
- Simon A;
- Katlama C;
- Yeni P;
- Descamps D;
- Aubron-Olivier C;
- Calvez V
Publication type:
Journal Article
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1475, doi. 10.1093/jac/dks047
By:
- Marcelin, A. G.;
- Charpentier, C.;
- Wirden, M.;
- Landman, R.;
- Valantin, M. A.;
- Simon, A.;
- Katlama, C.;
- Yeni, P.;
- Descamps, D.;
- Aubron-Olivier, C.;
- Calvez, V.
Publication type:
Article
Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.
Published in:
2012
By:
- Valantin MA;
- Lambert-Niclot S;
- Flandre P;
- Morand-Joubert L;
- Cabiè A;
- Meynard JL;
- Ponscarme D;
- Ajana F;
- Slama L;
- Curjol A;
- Cuzin L;
- Schneider L;
- Taburet AM;
- Marcelin AG;
- Katlama C;
- MONOI ANRS 136 Study Group
Publication type:
Journal Article
Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 691
By:
- Valantin, M. A.;
- Lambert-Niclot, S.;
- Flandre, P.;
- Morand-Joubert, L.;
- Cabiè, A.;
- Meynard, J. L.;
- Ponscarme, D.;
- Ajana, F.;
- Slama, L.;
- Curjol, A.;
- Cuzin, L.;
- Schneider, L.;
- Taburet, A. M.;
- Marcelin, A. G.;
- Katlama, C.
Publication type:
Article
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir.
Published in:
2011
By:
- Bommenel T;
- Launay O;
- Meynard JL;
- Gilquin J;
- Katlama C;
- Lascaux AS;
- Mahamat A;
- Martinez V;
- Pradier C;
- Rouveix E;
- Simon A;
- Costagliola D;
- Abgrall S;
- FHDH-ANRS CO4
Publication type:
Journal Article
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 8, p. 1869
By:
- Bommenel, T.;
- Launay, O.;
- Meynard, J. L.;
- Gilquin, J.;
- Katlama, C.;
- Lascaux, A. S.;
- Mahamat, A.;
- Martinez, V.;
- Pradier, C.;
- Rouveix, E.;
- Simon, A.;
- Costagliola, D.;
- Abgrall, S.
Publication type:
Article
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients.
Published in:
2010
By:
- Valantin MA;
- Bittar R;
- de Truchis P;
- Bollens D;
- Slama L;
- Giral P;
- Bonnefont-Rousselot D;
- Pétour P;
- Aubron-Olivier C;
- Costagliola D;
- Katlama C;
- TOTEM trial group;
- Valantin, M A;
- Bittar, R;
- de Truchis, P;
- Bollens, D;
- Slama, L;
- Giral, P;
- Bonnefont-Rousselot, D;
- Pétour, P
Publication type:
journal article
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 3, p. 556, doi. 10.1093/jac/dkp462
By:
- Valantin, M. A.;
- Bittar, R.;
- de Truchis, P.;
- Bollens, D.;
- Slama, L.;
- Giral, P.;
- Bonnefont-Rousselot, D.;
- Pétour, P.;
- Aubron-Olivier, C.;
- Costagliola, D.;
- Katlama, C.
Publication type:
Article
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
Published in:
2009
By:
- Landman R;
- Capitant C;
- Descamps D;
- Chazallon C;
- Peytavin G;
- Katlama C;
- Pialoux G;
- Bentata M;
- Brun-Vézinet F;
- Aboulker J;
- Yéni P
Publication type:
Journal Article
A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients.
Published in:
2009
By:
- Girard P;
- Cabié A;
- Michelet C;
- Verdon R;
- Katlama C;
- Mercié P;
- Morand-Joubert L;
- Pétour P;
- Monchecourt F;
- Chêne G;
- Trylesinski A
Publication type:
Journal Article
Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994–2001.
Published in:
European Journal of Clinical Microbiology & Infectious Diseases, 2004, v. 23, n. 7, p. 550, doi. 10.1007/s10096-004-1160-2
By:
- Yust, I.;
- Fox, Z.;
- Burke, M.;
- Johnson, A.;
- Turner, D.;
- Mocroft, A.;
- Katlama, C.;
- Ledergerber, B.;
- Reiss, P.;
- Kirk, O.
Publication type:
Article
3TC+ PI dual therapy during pregnancy for PMTCT of HIV-1-naïve or pretreated women.
Published in:
Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18222
By:
- Gliga, S;
- Clavel, C;
- Alix, A;
- Dommergue, M;
- Quetin, F;
- Marcelin, A;
- Stitou, H;
- Schneider, L;
- Calin, R;
- Caby, F;
- Valantin, M;
- Mellon, G;
- Seang, S;
- Katlama, C;
- Tubiana, R
Publication type:
Article
Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. P41, doi. 10.1186/1758-2652-13-S4-P41
By:
- Ghosn, J;
- Chermak, A;
- Houssaini, A;
- Peytavin, G;
- Lambert-Niclot, S;
- Eychenne, N;
- Slama, L;
- Brunet, A;
- Duvivier, C;
- Simon, A;
- Marcelin, AG;
- Flandre, P;
- Katlama, C
Publication type:
Article
Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. O21, doi. 10.1186/1758-2652-13-S4-O21
By:
- Bommenel, T;
- Meynard, JL;
- Launay, O;
- Simon, A;
- Mahamat, A;
- Martinez, V;
- Gilquin, J;
- Katlama, C;
- Lascaux, AS;
- Pradier, C;
- Rouveix, E;
- Costagliola, D;
- Abgrall, S
Publication type:
Article
Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961).
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. O51, doi. 10.1186/1758-2652-13-S4-O51
By:
- Eron, J;
- Livrozet, JM;
- Morlat, P;
- Lazzarin, A;
- Katlama, C;
- Hawkins, T;
- Fujiwara, T;
- Cuffe, R;
- Vavro, C;
- Santiago, J;
- Ait-Khaled, M;
- Min, S;
- Yeo, JM
Publication type:
Article
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study.
Published in:
Journal of the International AIDS Society, 2010, v. 13, p. P29, doi. 10.1186/1758-2652-13-S4-P29
By:
- Schneider, L;
- Houssaini, A;
- Lambert, S;
- Peytavin, G;
- Agher, R;
- Chermak, A;
- Flandre, P;
- Calvez, V;
- Marcelin, AG;
- Ghosn, J;
- Katlama, C
Publication type:
Article
Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study.
Published in:
2010
By:
- Ghosn, J.;
- Chermak, A.;
- Houssaini, A.;
- Peytavin, G.;
- Lambert-Niclot, S.;
- Eychenne, N.;
- Slama, L.;
- Brunet, A.;
- Duvivier, C.;
- Simon, A.;
- Marcelin, A. G.;
- Flandre, P.;
- Katlama, C.
Publication type:
Abstract
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study.
Published in:
2010
By:
- Schneider, L.;
- Houssaini, A.;
- Lambert, S.;
- Peytavin, G.;
- Agher, R.;
- Chermak, A.;
- Flandre, P.;
- Calvez, V.;
- Marcelin, A. G.;
- Ghosn, J.;
- Katlama, C.
Publication type:
Abstract
Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961).
Published in:
2010
By:
- Eron, J.;
- Livrozet, J. M.;
- Morlat, P.;
- Lazzarin, A.;
- Katlama, C.;
- Hawkins, T.;
- Fujiwara, T.;
- Cuffe, R.;
- Vavro, C.;
- Santiago, J.;
- Ait-Khaled, M.;
- Min, S.;
- Yeo, J. M.
Publication type:
Abstract
O215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens.
Published in:
2010
By:
- Bommenel, T.;
- Meynard, J. L.;
- Launay, O.;
- Simon, A.;
- Mahamat, A.;
- Martinez, V.;
- Gilquin, J.;
- Katlama, C.;
- Lascaux, A. S.;
- Pradier, C.;
- Rouveix, E.;
- Costagliola, D.;
- Abgrall, S.
Publication type:
Abstract
CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity.
Published in:
International Immunology, 1998, v. 10, n. 3, p. 311, doi. 10.1093/intimm/10.3.311
By:
- Mollet, L;
- Sadat-Sowti, B;
- Duntze, J;
- Leblond, V;
- Bergeron, F;
- Calvez, V;
- Katlama, C;
- Debré, P;
- Autran, B
Publication type:
Article
The pseudo-Sézary syndrome with CD8 phenotype in a patient with the acquired immunodeficiency syndrome (AIDS).
Published in:
1989
By:
- Janier, Michel;
- Kalama, Christine;
- Flagent, Beatrice;
- Valensi, Francoise;
- Moulonguet, Isabelle;
- Sigaux, Francois;
- Dompmartin, Denise;
- Civatte, Jean;
- Janier, M;
- Katlama, C;
- Flageul, B;
- Valensi, F;
- Moulonguet, I;
- Sigaux, F;
- Dompmartin, D;
- Civatte, J
Publication type:
journal article
Pentamidine and pancreatitis.
Published in:
1986
By:
- Salmeron, S;
- Petitpretz, P;
- Katlama, C;
- Herve, P;
- Brivet, F;
- Simonneau, G;
- Duroux, P;
- Regnier, B
Publication type:
Case Study
Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.
Published in:
1997
By:
- Mayaux, Marie Jeanne;
- Dussaix, Elisabeth;
- Isopet, Jacques;
- Rekacewicz, Claire;
- Mandelbrot, Laurent>;
- Ciraru-Vigneron, Nicole;
- Allemon, Marie Christine;
- Chambrin, Véronique;
- Katlama, Christine;
- Delfraissy, Jean François;
- Puel, Jacqueline;
- Mayaux, M J;
- Dussaix, E;
- Isopet, J;
- Rekacewicz, C;
- Mandelbrot, L;
- Ciraru-Vigneron, N;
- Allemon, M C;
- Chambrin, V;
- Katlama, C
Publication type:
journal article
Treatment of AIDS-Associated Gastrointestinal Cytomegalovirus Infection with Foscarnet and Ganciclovir: A Randomized Comparison.
Published in:
Journal of Infectious Diseases, 1995, v. 172, n. 3, p. 622, doi. 10.1093/infdis/172.3.622
By:
- Blanshard, C.;
- Benhamou, Y.;
- Dohin, E.;
- Lernestedt, J.-O.;
- Gazzard, B. G.;
- Katlama, C.
Publication type:
Article
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.
Published in:
Infection, 2014, v. 42, n. 2, p. 295, doi. 10.1007/s15010-013-0542-8
By:
- Caby, F.;
- Schneider, L.;
- Blanc, C.;
- Soulié, C.;
- Tindel, M.;
- Peytavin, G.;
- Agher, R.;
- Valantin, M.;
- Tubiana, R.;
- Wirden, M.;
- Calvez, V.;
- Marcelin, A.;
- Katlama, C.
Publication type:
Article
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.
Published in:
2013
By:
- Eron JJ;
- Clotet B;
- Durant J;
- Katlama C;
- Kumar P;
- Lazzarin A;
- Poizot-Martin I;
- Richmond G;
- Soriano V;
- Ait-Khaled M;
- Fujiwara T;
- Huang J;
- Min S;
- Vavro C;
- Yeo J;
- VIKING Study Group;
- Eron, Joseph J;
- Clotet, Bonaventura;
- Durant, Jacques;
- Katlama, Christine
Publication type:
journal article
Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/Ritonavir Monotherapy.
Published in:
2011
By:
- Lambert-Niclot S;
- Flandre P;
- Valantin MA;
- Peytavin G;
- Duvivier C;
- Haim-Boukobza S;
- Algarte-Genin M;
- Yazdanpanah Y;
- Girard PM;
- Katlama C;
- Calvez V;
- Marcelin AG
Publication type:
Journal Article
Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin as a single agent.
Published in:
1990
By:
- Lassoued, Kaïss;
- Clauvel, Jean-Pierre;
- Katlama, Christine;
- Janier, Michel;
- Picard, Catherine;
- Matheron, Sophie;
- Lassoued, K;
- Clauvel, J P;
- Katlama, C;
- Janier, M;
- Picard, C;
- Matheron, S
Publication type:
journal article
Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen*.
Published in:
Journal of Medical Virology, 2001, v. 65, n. 3, p. 445, doi. 10.1002/jmv.2055
By:
- Delaugerre, C.;
- Rohban, R.;
- Simon, A.;
- Mouroux, M.;
- Tricot, C.;
- Agher, R.;
- Huraux, J.M.;
- Katlama, C.;
- Calvez, V.
Publication type:
Article
Cytomegalovirus infection in acquired immune-deficiency syndrome.
Published in:
Journal of Medical Virology, 1993, v. 41, n. S1, p. 128, doi. 10.1002/jmv.1890410525
By:
- Katlama, C.
Publication type:
Article
T cell receptorγ/δ<sup>+</sup> lymphocyte subsets during HIV infection.
Published in:
Clinical & Experimental Immunology, 1989, v. 75, n. 2, p. 206
By:
- Autran, B.;
- Triebel, F.;
- Katlama, C.;
- Rozenbaum, W.;
- Hercend, T.;
- Debre, P.
Publication type:
Article
Astrocytic adhesion molecules are increased in HIV-1-associated cognitive/motor complex.
Published in:
Neuropathology & Applied Neurobiology, 1997, v. 23, n. 2, p. 83, doi. 10.1111/j.1365-2990.1997.tb01190.x
By:
- Seilhean, D.;
- Dzia-Lepfoundzou, A.;
- Sazdovitch, V.;
- Cannella, B.;
- Raine, C. S.;
- Katlama, C.;
- Bricaire, F.;
- Duyckaerts, C.;
- Hauw, J.-J.
Publication type:
Article
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.
Published in:
1999
By:
- Miller, Veronica;
- Mocroft, Amanda;
- Miller, V;
- Mocroft, A;
- Reiss, P;
- Katlama, C;
- Papadopoulos, A I;
- Katzenstein, T;
- van Lunzen, J;
- Antunes, F;
- Phillips, A N;
- Lundgren, J D
Publication type:
journal article
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.
Published in:
1998
By:
- Katlama, Christine;
- Valantin, Marc-Antoine;
- Katlama, C;
- Valantin, M A;
- Matheron, S;
- Coutellier, A;
- Calvez, V;
- Descamps, D;
- Longuet, C;
- Bonmarchand, M;
- Tubiana, R;
- De Sa, M;
- Lancar, R;
- Agut, H;
- Brun-Vezinet, F;
- Costagliola, D
Publication type:
journal article
HIV-related non-Hodgkin's lymphoma among European AIDS patients.
Published in:
European Journal of Haematology, 1995, v. 55, n. 4, p. 245, doi. 10.1111/j.1600-0609.1995.tb00265.x
By:
- Pedersen, C.;
- Barton, S. E.;
- Chiesi, A.;
- Skinhøj, P.;
- Katlama, C.;
- Johnson, A.;
- Lunzen, J.;
- Hirschel, B.;
- Maayan, S.;
- Lundgren, J. D.
Publication type:
Article
Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery.
Published in:
HIV Medicine, 2019, v. 20, n. 5, p. 353, doi. 10.1111/hiv.12732
By:
- Assoumou, L;
- Thormann, F;
- Soulié, C;
- Caby, F;
- Dudoit, Y;
- Marcelin, A‐G;
- Goudot, P;
- Blanc, C;
- Coriat, P;
- Katlama, C;
- Costagliola, D;
- Pourcher, V
Publication type:
Article
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.
Published in:
HIV Medicine, 2017, v. 18, n. 9, p. 696, doi. 10.1111/hiv.12508
By:
- Todesco, E;
- Charpentier, C;
- Bertine, M;
- Wirden, M;
- Storto, A;
- Desire, N;
- Grude, M;
- Nguyen, T;
- Sayon, S;
- Yazdanpanah, Y;
- Katlama, C;
- Descamps, D;
- Calvez, V;
- Marcelin, AG
Publication type:
Article
Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
Published in:
HIV Medicine, 2017, v. 18, n. 6, p. 395, doi. 10.1111/hiv.12441
By:
- Cuzin, L;
- Katlama, C;
- Cotte, L;
- Pugliese, P;
- Cheret, A;
- Bernaud, C;
- Rey, D;
- Poizot‐Martin, I;
- Chirouze, C;
- Bani‐Sadr, F;
- Cabié, A;
- Brégigeon, S.;
- Zaegel‐Faucher, O.;
- Obry‐Roguet, V.;
- Orticoni, M.;
- Soavi, M. J.;
- Luquet‐Besson, I.;
- Ressiot, E.;
- Carta‐ Padovani, M.;
- Ducassou, M. J.
Publication type:
Article
Comparative risk of failure of ABC/3 TC or TDF/ FTC based first-line regimens in patients with a high viral load.
Published in:
HIV Medicine, 2016, v. 17, n. 5, p. 380, doi. 10.1111/hiv.12306
By:
- Flandre, P;
- Pugliese, P;
- Allavena, C;
- Katlama, C;
- Cotte, L;
- Cheret, A;
- Cabié, A;
- Rey, D;
- Chirouze, C;
- Bani‐Sadr, F;
- Cuzin, L;
- Enel, P.;
- Obry‐Roguet, V.;
- Faucher, O.;
- Bregigeon, S.;
- Poizot‐Martin, I.;
- Marchou, B.;
- Massip, P.;
- Bonnet, E.;
- Obadia, M.
Publication type:
Article
Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
Published in:
HIV Medicine, 2015, v. 16, n. 9, p. 553, doi. 10.1111/hiv.12257
By:
- Hattab, S;
- Guiguet, M;
- Carcelain, G;
- Fourati, S;
- Guihot, A;
- Autran, B;
- Caby, F;
- Marcelin, A‐G;
- Costagliola, D;
- Katlama, C
Publication type:
Article
High rate of hepatitis C virus ( HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.
Published in:
HIV Medicine, 2014, v. 15, n. 10, p. 615, doi. 10.1111/hiv.12160
By:
- Peters, L;
- Mocroft, A;
- Soriano, V;
- Rockstroh, JK;
- Kirkby, N;
- Reiss, P;
- Katlama, C;
- Zakharova, N;
- Flisiak, R;
- Lundgren, JD
Publication type:
Article
Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy
Published in:
HIV Medicine, 2012, v. 13, n. 8, p. 505, doi. 10.1111/j.1468-1293.2012.01004.x
By:
- Valantin, MA;
- Kolta, S;
- Flandre, P;
- Algarte Genin, M;
- Meynard, JL;
- Ponscarme, D;
- Slama, L;
- Cuzin, L;
- Kerviler, E;
- Inaoui, R;
- Katlama, C
Publication type:
Article
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.
Published in:
2011
By:
- Vrouenraets, Sme;
- Wit, Fwnm;
- Fernandez Garcia, E;
- Moyle, Gj;
- Jackson, Ag;
- Allavena, C;
- Raffi, F;
- Jayaweera, Dt;
- Mauss, S;
- Katlama, C;
- Fisher, M;
- Slama, L;
- Hardy, Wd;
- DeJesus, E;
- van Eeden, A;
- Reiss, P
Publication type:
Journal Article
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.
Published in:
HIV Medicine, 2011, v. 12, n. 10, p. 620, doi. 10.1111/j.1468-1293.2011.00941.x
By:
- Vrouenraets, SME;
- Wit, FWNM;
- Fernandez Garcia, E;
- Moyle, GJ;
- Jackson, AG;
- Allavena, C;
- Raffi, F;
- Jayaweera, DT;
- Mauss, S;
- Katlama, C;
- Fisher, M;
- Slama, L;
- Hardy, WD;
- DeJesus, E;
- van Eeden, A;
- Reiss, P
Publication type:
Article
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.
Published in:
HIV Medicine, 2011, v. 12, n. 5, p. 259, doi. 10.1111/j.1468-1293.2010.00877.x
By:
- Reekie, J.;
- Reiss, P.;
- Ledergerber, B.;
- Sedlacek, D.;
- Parczewski, M.;
- Gatell, J.;
- Katlama, C.;
- F&;#x00E4;tkenheuer, G.;
- Lundgren, J. D.;
- Mocroft, A.
Publication type:
Article
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients.
Published in:
2010
By:
- Lambert-Niclot S;
- Machouf N;
- Peytavin G;
- Soulie C;
- Wirden M;
- Simon A;
- Murphy R;
- Katlama C;
- Thomas R;
- Calvez V;
- Marcelin A
Publication type:
Journal Article
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients S Lambert-Niclot et al. Atazanavir inhibitory quotient in first-line therapy
Published in:
HIV Medicine, 2010, v. 11, n. 10, p. 666, doi. 10.1111/j.1468-1293.2010.00839.x
By:
- Lambert-Niclot, S.;
- Machouf, N.;
- Peytavin, G.;
- Soulie, C.;
- Wirden, M.;
- Simon, A.;
- Murphy, R. L.;
- Katlama, C.;
- Thomas, R.;
- Calvez, V.;
- Marcelin, A.-G.
Publication type:
Article
Is long-term virological response related to CCR5 [Delta]32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
Published in:
2010
By:
- Laurichesse J;
- Taieb A;
- Capoulade-Metay C;
- Katlama C;
- Villes V;
- Drobacheff-Thiebaud M;
- Raffi F;
- Chêne G;
- Theodorou I;
- Leport C;
- ANRS C08 Aproco-Copilote Study Group
Publication type:
Journal Article

Found: 95